CAPTRUST Financial Advisors
INMB icon

CAPTRUST Financial Advisors’s INmune Bio INMB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3K Buy
+11,234
New +$15.5K ﹤0.01% 3211
2022
Q3 		– Sell
-269
Closed -$2K – 3025
2022
Q2 		$2K Hold
269
– – ﹤0.01% 4471
2022
Q1 		$2K Hold
269
– – ﹤0.01% 4493
2021
Q4 		$3K Sell
269
-131
-33% -$1.94K ﹤0.01% 4278
2021
Q3 		$8K Hold
400
– – ﹤0.01% 3735
2021
Q2 		$7K Buy
+400
New +$5.39K ﹤0.01% 3707

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CAPTRUST Financial Advisors's INMB Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in INmune Bio (INMB) in Q2 2026: 11,234 shares worth $18.3K. The stake represents ﹤0.01% of the portfolio and ranks #3211 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in INMB as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in INMB in Q2 2021 and has held it in 6 quarters since. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • CAPTRUST Financial Advisors held 11,234 shares of INmune Bio worth $18.3K as of Q2 2026.
  • INmune Bio was a new CAPTRUST Financial Advisors position in Q2 2026.
  • INmune Bio made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3211 holding.
  • CAPTRUST Financial Advisors first reported a position in INmune Bio in Q2 2021 and has held it in 6 quarters since.
  • 83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.